Complications of Self-Injected Facial Fillers: A Treatment Conundrum in the UK

    January 2019 in “ Case Reports in Surgery ”
    Jessica Blanchard, Julia Palmer, Enamul Ali, Leo Cheng
    TLDR Self-injected facial fillers can cause serious health issues and misdiagnoses.
    The document discussed the complications arising from self-injected facial fillers, highlighting a case of a 24-year-old female who experienced upper lip swelling after using a dermal filler purchased online. The patient initially presented with symptoms that could be mistaken for oral cancer, but it was determined to be a granulomatous reaction to the filler. The case underscored the lack of regulation and awareness regarding the risks of self-administered fillers, as well as the absence of a defined treatment pathway for such complications within the UK healthcare system. The report called for better regulation, public awareness, and training for healthcare professionals to manage these complications effectively. The total cost of the patient's treatment to the NHS was £323.17, and the case emphasized the need for a conversation about the NHS's role in managing complications from private cosmetic procedures.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 950 results

    Similar Research

    5 / 1000+ results
      Acne and Acneiform Eruptions

      research Acne and Acneiform Eruptions

      2 citations , January 2011 in “Elsevier eBooks”
      Early treatment of acne is crucial to prevent scarring and psychological effects.
      Dermatologic Care for Lesbian, Gay, Bisexual, and Transgender Persons

      research Dermatologic Care for Lesbian, Gay, Bisexual, and Transgender Persons

      47 citations , February 2019 in “Journal of The American Academy of Dermatology”
      LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

      research Subject Index

      February 2009 in “Journal of the American Academy of Dermatology”

      research Jak-Inhibitors Beyond The Label: Emerging Applications In Dermatology

      January 2026 in “Medicina”
      Oral Janus kinase (JAK) inhibitors, including abrocitinib, upadacitinib, baricitinib, and ritlecitinib, are being used off-label in dermatology for a variety of inflammatory skin disorders beyond their approved uses for atopic dermatitis and alopecia areata. A review of 136 articles involving 204 patients found these inhibitors to be effective and generally well-tolerated, with mild adverse events in a minority of cases. Baricitinib, in particular, has shown promise in treating autoimmune and inflammatory skin diseases, such as autoimmune bullous diseases, lupus-related dermatoses, and vitiligo, often achieving rapid symptom control and sustained remission. The findings suggest that JAK inhibitors have significant therapeutic potential in dermatology, offering new treatment options for conditions that lack standardized therapies.